Back to search

C&C Pharma Ltd

09719856

active
Private Limited Company
Companies House
Health Score
70 / 100

Some Concerns

30/30
Filing
0/30
Financial
40/40
Risk
  • Negative net worth (-10)
  • Current liabilities exceed current assets (-10)

Details

THE MAISES, LEOMINSTER, HR6 8DZ
Incorporated 05/08/2015

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

72110
Research and experimental development on biotechnology

Officers

Mrs Elizabeth Ann Coxon

director · Since 05/08/2015

DIRECTOR

BRITISH · UNITED KINGDOM · Age 65

Mr Andrew Michael Croxson

director · Since 05/08/2015

DIRECTOR

BRITISH · ENGLAND · Age 61

Also on 2 other boards

Persons with Significant Control

Ms Elizabeth Ann Coxon

75–100% shares

British · United Kingdom · Age 65

The Maises, Bridge Street, Leominster, HR6 8DZ

Notified 06/04/2016

CompanyRankvs 2397+ SIC 72110 peers
38

Financial strength12th percentile among SIC peers · 3/25
Employees47th percentile among SIC peers · 7/15
LiquidityCurrent ratio 0.18× · 2/20
Longevity11 years trading (max 15) · 11/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength3/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees7/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity2/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity11/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/08/2025

Net Worth

-£33k

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

-£79k

Working capital

Current Assets

£17k

Current Liabilities

£96k

Fixed Assets

£46k

1avg. employees

Balance Sheet

Assets less current liabilities-£33k
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent RatioImplied Profit
20250.18-£9k
20240.21-£11k
20230.27
20220.42
20212.03
20201.00
20194.12+£6k
20182.32

Derived from filed accounts. Not audited figures.